SHL Telemedicine Ltd. (SHLT)
USD 3.02
(-13.69%)
USD 3.02
(-13.69%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 19.85 Million USD | -25.77% |
| 2022 | 26.74 Million USD | -17.72% |
| 2021 | 32.5 Million USD | 123.1% |
| 2020 | 14.56 Million USD | 18.67% |
| 2019 | 12.27 Million USD | 1217.17% |
| 2018 | 932 Thousand USD | -93.53% |
| 2017 | 14.4 Million USD | -38.65% |
| 2016 | 23.48 Million USD | 18.61% |
| 2015 | 19.79 Million USD | -14.57% |
| 2014 | 23.17 Million USD | -19.2% |
| 2013 | 28.68 Million USD | 1.0% |
| 2012 | 28.39 Million USD | -10.07% |
| 2011 | 31.58 Million USD | 1237.0% |
| 2010 | 2.36 Million USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | -100.0% |
| 2007 | 50.07 Million USD | -32.28% |
| 2006 | 73.94 Million USD | 126.48% |
| 2005 | 32.64 Million USD | -24.46% |
| 2004 | 43.21 Million USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 11.14 Million USD | 60.75% |
| 2024 Q1 | 11.14 Million USD | -43.87% |
| 2023 Q1 | 22.26 Million USD | -16.73% |
| 2023 Q3 | 17.42 Million USD | -29.36% |
| 2023 Q4 | 19.85 Million USD | 13.93% |
| 2023 FY | 19.85 Million USD | -25.77% |
| 2023 Q2 | 24.66 Million USD | 10.77% |
| 2022 Q1 | 25.64 Million USD | -21.08% |
| 2022 Q3 | 24.47 Million USD | -12.07% |
| 2022 Q4 | 26.74 Million USD | 9.24% |
| 2022 FY | 26.74 Million USD | -17.72% |
| 2022 Q2 | 27.83 Million USD | 8.53% |
| 2021 Q4 | 32.5 Million USD | 7.76% |
| 2021 Q2 | 11.2 Million USD | 16.93% |
| 2021 Q1 | 9.58 Million USD | -34.23% |
| 2021 FY | 32.5 Million USD | 123.1% |
| 2021 Q3 | 30.16 Million USD | 169.21% |
| 2020 Q1 | 12.9 Million USD | 5.15% |
| 2020 Q4 | 14.56 Million USD | 12.47% |
| 2020 Q2 | 14.08 Million USD | 9.14% |
| 2020 FY | 14.56 Million USD | 18.67% |
| 2020 Q3 | 12.95 Million USD | -8.06% |
| 2019 Q3 | 10.95 Million USD | 144.15% |
| 2019 Q1 | 4.17 Million USD | 347.64% |
| 2019 Q2 | 4.48 Million USD | 7.55% |
| 2019 FY | 12.27 Million USD | 1217.17% |
| 2019 Q4 | 12.27 Million USD | 12.06% |
| 2018 Q1 | 11.76 Million USD | -18.34% |
| 2018 FY | 932 Thousand USD | -93.53% |
| 2018 Q4 | 932 Thousand USD | 0.0% |
| 2018 Q3 | 932 Thousand USD | -92.08% |
| 2018 Q2 | 11.76 Million USD | 0.0% |
| 2017 FY | 14.4 Million USD | -38.65% |
| 2017 Q2 | 23.31 Million USD | 0.0% |
| 2017 Q1 | 23.31 Million USD | -0.72% |
| 2017 Q4 | 14.4 Million USD | 0.0% |
| 2017 Q3 | 14.4 Million USD | -38.21% |
| 2016 Q1 | 21.3 Million USD | 7.61% |
| 2016 FY | 23.48 Million USD | 18.61% |
| 2016 Q4 | 23.48 Million USD | 0.0% |
| 2016 Q3 | 23.48 Million USD | 10.22% |
| 2016 Q2 | 21.3 Million USD | 0.0% |
| 2015 Q2 | 22.15 Million USD | 2.5% |
| 2015 Q1 | 21.61 Million USD | -6.75% |
| 2015 Q4 | 19.79 Million USD | 0.0% |
| 2015 FY | 19.79 Million USD | -14.57% |
| 2015 Q3 | 19.79 Million USD | -10.62% |
| 2014 Q2 | 27.13 Million USD | -3.94% |
| 2014 Q1 | 28.25 Million USD | -1.5% |
| 2014 FY | 23.17 Million USD | -19.2% |
| 2014 Q4 | 23.17 Million USD | -3.66% |
| 2014 Q3 | 24.05 Million USD | -11.36% |
| 2013 Q4 | 28.68 Million USD | -1.17% |
| 2013 FY | 28.68 Million USD | 1.0% |
| 2013 Q1 | 28.02 Million USD | -1.31% |
| 2013 Q2 | 28.08 Million USD | 0.19% |
| 2013 Q3 | 29.02 Million USD | 3.34% |
| 2012 Q2 | 26.08 Million USD | -18.4% |
| 2012 Q4 | 28.39 Million USD | 12.5% |
| 2012 FY | 28.39 Million USD | -10.07% |
| 2012 Q1 | 31.96 Million USD | 1.21% |
| 2012 Q3 | 25.24 Million USD | -3.21% |
| 2011 Q3 | 33.28 Million USD | 265.5% |
| 2011 Q2 | 9.1 Million USD | 21.07% |
| 2011 Q1 | 7.52 Million USD | 218.46% |
| 2011 FY | 31.58 Million USD | 1237.0% |
| 2011 Q4 | 31.58 Million USD | -5.13% |
| 2010 Q4 | 2.36 Million USD | 181.19% |
| 2010 Q1 | 1.83 Million USD | 0.0% |
| 2010 Q2 | - USD | -100.0% |
| 2010 Q3 | 840 Thousand USD | 0.0% |
| 2010 FY | 2.36 Million USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q2 | 528 Thousand USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2008 FY | - USD | -100.0% |
| 2007 FY | 50.07 Million USD | -32.28% |
| 2006 FY | 73.94 Million USD | 126.48% |
| 2005 FY | 32.64 Million USD | -24.46% |
| 2004 FY | 43.21 Million USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Inovalon Holdings, Inc. | 897.3 Million USD | 97.788% |
| GE HealthCare Technologies Inc. | 9.86 Billion USD | 99.799% |
| Sharecare, Inc. | 2.34 Million USD | -746.53% |
| Progyny, Inc. | 19.39 Million USD | -2.378% |
| Aclarion, Inc. | 1.12 Million USD | -1663.409% |
| CareMax, Inc. | 491.93 Million USD | 95.965% |
| Simulations Plus, Inc. | 475 Thousand USD | -4079.183% |
| CareCloud, Inc. | 14.73 Million USD | -34.739% |
| Forian Inc. | 23 Million USD | 13.697% |
| Bullfrog AI Holdings, Inc. Warrants | - USD | -Infinity% |
| Bullfrog AI Holdings, Inc. Common Stock | - USD | -Infinity% |
| Minerva Surgical, Inc. | 39.69 Million USD | 49.985% |
| Omnicell, Inc. | 614.09 Million USD | 96.767% |
| Definitive Healthcare Corp. | 267.92 Million USD | 92.591% |
| Zhongchao Inc. | 808.15 Thousand USD | -2356.347% |
| Accolade, Inc. | 241.64 Million USD | 91.785% |
| Streamline Health Solutions, Inc. | 10.56 Million USD | -87.877% |
| Ontrak, Inc. | 1.68 Million USD | -1075.318% |
| SOPHiA GENETICS SA | 18.6 Million USD | -6.721% |
| R1 RCM Inc. | 1.74 Billion USD | 98.859% |
| Spok Holdings, Inc. | 11.08 Million USD | -79.065% |
| Privia Health Group, Inc. | 8.28 Million USD | -139.487% |
| EUDA Health Holdings Limited | 3.37 Million USD | -488.264% |
| HeartBeam, Inc. | - USD | -Infinity% |
| GeneDx Holdings Corp. | 119.77 Million USD | 83.426% |
| TruBridge, Inc. | 203.28 Million USD | 90.235% |
| Nutex Health, Inc. | 275.75 Million USD | 92.801% |
| Renalytix Plc | 8.53 Million USD | -132.585% |
| Sharecare, Inc. | 2.34 Million USD | -746.53% |
| Health Catalyst, Inc. | 249.06 Million USD | 92.03% |
| 10x Genomics, Inc. | 95.37 Million USD | 79.185% |
| GoodRx Holdings, Inc. | 711.07 Million USD | 97.208% |
| SCWorx Corp. | 90.35 Thousand USD | -21869.164% |
| Schrödinger, Inc. | 127.88 Million USD | 84.477% |
| HealthEquity, Inc. | 933.14 Million USD | 97.873% |
| HealthStream, Inc. | 23.22 Million USD | 14.512% |
| MSP Recovery, Inc. | 679.32 Million USD | 97.078% |
| Augmedix, Inc. | 25.84 Million USD | 23.195% |
| BrightSpring Health Services, Inc. Common Stock | 3.67 Billion USD | 99.459% |
| Ontrak, Inc. | 1.68 Million USD | -1075.318% |
| CareCloud, Inc. | 14.73 Million USD | -34.739% |
| Premier, Inc. | 126 Million USD | 84.245% |
| Certara, Inc. | 298.19 Million USD | 93.343% |
| GeneDx Holdings Corp. | 119.77 Million USD | 83.426% |
| OneMedNet Corporation | 5.1 Million USD | -289.137% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 3.67 Billion USD | 99.459% |
| EUDA Health Holdings Limited | 3.37 Million USD | -488.264% |
| HeartBeam, Inc. | - USD | -Infinity% |
| CareCloud, Inc. | 14.73 Million USD | -34.739% |
| Mangoceuticals, Inc. | 128.67 Thousand USD | -15326.97% |
| CareMax, Inc. | 491.93 Million USD | 95.965% |
| Healthcare Triangle, Inc. | 4.31 Million USD | -359.836% |
| National Research Corporation | 38.95 Million USD | 49.042% |
| Aclarion, Inc. | 1.12 Million USD | -1663.409% |
| OptimizeRx Corporation | 36.82 Million USD | 46.092% |